{"schema_version":"secwatch.filing_event.v1","accession":"0001999371-26-004897","form_type":"8-K","ticker":"TNXP","cik":"0001430306","company_name":"Tonix Pharmaceuticals Holding Corp.","filed_at":"2026-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.064888+00:00","generated_at":"2026-05-15T22:08:16.588538+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other","sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Tonix Pharmaceuticals uplists from Nasdaq Capital Market to Global Select Market","bullets":["Nasdaq approved transfer of TNXP common stock, effective March 3, 2026, ticker unchanged.","Uplisting reflects compliance with higher financial and corporate governance standards.","CEO Seth Lederman noted uplisting may enhance visibility, liquidity, and institutional access."],"urls":{"canonical":"https://secwatch.observer/filing/0001999371-26-004897","json":"https://secwatch.observer/filing/0001999371-26-004897.json","markdown":"https://secwatch.observer/filing/0001999371-26-004897.md","text":"https://secwatch.observer/filing/0001999371-26-004897.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126004897/0001999371-26-004897-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126004897/tnxp-8k_030326.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T22:08:16.588538+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}